InProTher Alternatives & Competitors
12 companies similar to InProTher — InProTher is creating advanced cancer immunotherapies based on pre-clinical mode...
Companies similar to InProTher
ImmunOs Therapeutics AG
Novel human immunomodulatory proteins for cancer and autoimmune diseases with a specific r...
Schlieren, Switzerland
Imugene Limited
Bringing Effective New Treatments And Options To Patients Who Need Them
Australia
Alloplex Biotherapeutics Inc
A robust cellular therapeutic platform for treating cancer.
Boston, United States
Trillium Therapeutics Inc.
Clinical stage immuno-oncology company developing innovative therapies for the treatment o...
Cambridge, United States
Rival Readout
Competing with InProTher? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Inceptor Bio
Advancing Cell and Gene Therapies to Cure Cancer
Morrisville, United State...
ImmunoCellular Therapeutics Ltd
Pioneering immune-based therapies to harness the body's defenses against cancer through ad...
Calabasas, United States
FineImmu
Creating future health with advanced cell therapy drugs and precision immunodiagnostic pro...
NEOGAP Therapeutics AB
Science for cure.
Stockholm, Sweden
ImCheck Therapeutics
Bringing a novel class of Butyrophilin-targeted checkpoint modulators into the clinic
Marseille, France
NextPoint Therapeutics, Inc.
Launching a new world of precision therapeutics through its leading scientific work on th...
ImmunoGenesis, Inc.
Re-envisioning cold tumor treatment. Our deliberate drug development strategy targets mech...
Houston, United States
About InProTher
InProTher is a biotechnology startup founded in 2018, dedicated to creating cutting-edge cancer immunotherapies. The company's slogan, "InProTher is creating advanced cancer immunotherapies based on pre-clinical models with Professor Holst," succinctly captures its mission. With a focus on pioneering cancer immunothera...
Cancer Immunotherapy, Pre-clinical Models, Advanced Therapies, Immune Checkpoint Inhibitors, Tumor Immunity, Research Collaboration, Cancer Therapy Development, Immunotherapy Success, Professor Holst, Associate Professor Holst, Cancer Research, Cancer Treatment Innovations
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around InProTher: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at InProTher on 11 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
